71-Year-old man with chronic kidney failure and sudden change of mental status

Mayo Clinic Proceedings

Volumn 84, Issue 11, 2009, Pages e5-

  Mansfield, Aaron S ^a   Qian, Qi ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; ATORVASTATIN; BICARBONATE; CALCIUM ACETATE; CHLORIDE; CREATININE; ELECTROLYTE; FLUMAZENIL; GABAPENTIN; GLUCOSE; HEMOGLOBIN; INSULIN; NITROGEN; POTASSIUM; SODIUM; UREA; VANCOMYCIN;

AGED; AMPUTATION; ARTERIAL GAS; ARTERIOVENOUS FISTULA; ARTICLE; BICARBONATE BLOOD LEVEL; BRAIN ATROPHY; CASE REPORT; CHLORIDE BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; COMA; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CREATININE BLOOD LEVEL; DEPRESSION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; ELECTROLYTE BLOOD LEVEL; FOOT ULCER; GLUCOSE BLOOD LEVEL; HALLUCINATION; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; LEG ISCHEMIA; LEUKOCYTE COUNT; MALE; MENTAL HEALTH CARE; NEUROPATHIC PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PARKINSON DISEASE; PHYSICAL EXAMINATION; PNEUMONIA; POSTOPERATIVE CARE; POTASSIUM BLOOD LEVEL; SEIZURE; SODIUM BLOOD LEVEL; SOMNOLENCE; SURGICAL INFECTION; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL; URINARY TRACT INFECTION;

ACADEMIC MEDICAL CENTERS; AGED; AMINES; ANALGESICS; CONFUSION; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MENTAL DISORDERS; MINNESOTA; RENAL DIALYSIS; RISK ASSESSMENT; WITHHOLDING TREATMENT;

EID: 71249128393     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/84.11.e5     Document Type: Article

References (13)

1. Bassilios N, Launay-Vacher V, Khoury N, et al. Gabapentin neurotoxicity in a chronic haemodialysis patient [letter]. Nephrol Dial Transplant. 2001;16(10):2112-2113. (Pubitemid 32970587)
2. Dogukan A, Aygen B, Berilgen MS, et al. Gabapentin-induced coma in a patient with renal failure. Hemodial Int. 2006;10(2):168-169.
3. Brawek B, Löffler M, Dooley DJ, Weyerbrock A, Feuerstein TJ. Differential modulation of K(+)-evoked (3)H-neurotransmitter release from human neocortex by gabapentin and pregabalin. Naunyn Schmiedebergs Arch Pharmacol. 2008 Jan;376(5):301-307.
4. 2-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17537-17542. Epub 2006 Nov 6.
5. Rossi P, Serrao M, Pozzessere G. Gabapentin-induced worsening of neuropsychiatric symptoms in dementia with lewy bodies: case reports. Eur Neurol. 2002;47(1):56-57.
6. Raudino F, Mascalzi MG, Zagami A. Gabapentin and behavioral disorders in severe Alzheimer disease [letter]. J Clin Psychopharmacol. 2004;24(4):459-460. (Pubitemid 38944152)
7. Blum RA, Comstock TJ, Sica DA, et al. Pharmacokinetics of gabapentin in subjects with various degrees of renal function. Clin Pharmacol Ther. 1994;56(2):154-159. (Pubitemid 24274181)
8. Wong MO, Eldon MA, Keane WF, et al. Disposition of gabapentin in anuric subjects on hemodialysis. J Clin Pharmacol. 1995;35(6):622-626.
9. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038-2047. (Pubitemid 350074801)
10. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008;371(9631):2173-2182.
11. Luer MS, Hamani C, Dujovny M, et al. Saturable transport of gabapentin at the blood-brain barrier. Neurol Res. 1999;21(6):559-562. (Pubitemid 29426887)
12. 2+ channels. Annu Rev Cell Dev Biol. 2000;16:521-555.
13. Spafford JD, Zamponi GW. Functional interactions between presynaptic calcium channels and the neurotransmitter release machinery. Curr Opin Neurobiol. 2003;13(3):308-314. (Pubitemid 36792243)